Mesentech has developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue. The advantage of our technology is that exposure to the active pharmaceutical occurs only in the targeted tissues, thereby eliminating toxicity to unrelated organs.
Our first clinical program utilizes tissue-selective distribution to deliver prostaglandin, a potent hormone that triggers the body's own regenerative process, to musculoskeletal tissue to renew and repair muscle and bone.
Mesentech has developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue. The advantage of our technology is that exposure to the active pharmaceutical occurs only in the targeted tissues, thereby eliminating toxicity to unrelated organs.
Our first clinical program utilizes tissue-selective distribution to deliver prostaglandin, a potent hormone that triggers the body's own regenerative process, to musculoskeletal tissue to renew and repair muscle and bone.
